EUVIMEDEUVIMED entdecken
Crossref

Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence

Sara Abou Azar iD, Joseph Tobias, Megan Applewhite, Peter Angelos, Xavier M Keutgen

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Sara Abou Azar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Chicago Medicine, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Neuroendocrine, Thyroidectomy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Medullary thyroid cancer (MTC) has a historic recurrence rate up to 50%, and surgery remains the only cure.

Objective

This study aims to assess factors related to recurrence and metastatic spread in MTC.

Methods

Retrospective chart review was performed from 1990 to 2023 at a single specialized tertiary care referral center. Descriptive analysis and regression models were used for analysis. Sixty-eight patients with MTC, who underwent surgery, were included and the main outcome measure was recurrence.

Results

Median age at diagnosis was 54.9 years (42.2-64.1), 65% (n = 44) females. Lymph node and distant metastases were found in 24% (n = 16) and 4% (n = 3), respectively. RET mutations were present in 52% (n = 35): MTC risk levels were highest 6%, high 7%, and moderate 39%. Median tumor size was 1.9 cm (1.2-3.2) and median preoperative calcitonin was 504.4 pg/mL (133.2-1833.8). Total thyroidectomy (TT) was performed in 10 patients, TT + central neck dissection (CND) in 28, and TT + CND + lateral neck dissection (LND) in 25. On final pathology, 40% had positive central nodes and 25% had positive lateral nodes. Recurrence was 22%, median follow-up 4.7 years (1.2-28.0). Male gender (hazard ratio [HR] 5.81, P = .021), positive lateral neck nodes (HR 8.10, P = .011), and high/highest MTC risk level RET mutations (HR 8.66, P = .004) were significantly associated with recurrence. Preoperative calcitonin >2175 pg/mL was a strong predictor for distant metastasis (area under the curve [AUC] 0.893) and a good predictor for lateral neck disease (AUC 0.706). Extent of surgery was not significantly associated with recurrence (P = .634).

Conclusion

One of 4 patients undergoing surgery for MTC will recur. Risk factors associated with recurrence are male gender, lateral lymph node metastasis, and high/highest MTC risk level mutations, but not necessarily surgery type. Preoperative calcitonin >2175 pg/mL is suggestive of advanced disease and should prompt further evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsNeoplasm Recurrence, LocalCarcinoma, NeuroendocrineThyroidectomyHumansMaleFemaleMiddle AgedRetrospective StudiesAdultRisk FactorsMutationLymphatic MetastasisNeck DissectionProto-Oncogene Proteins c-retFollow-Up Studies

Stichwörter der Autor:innen

medullary thyroid cancerrecurrencethyroid surgery

Substanzen

Proto-Oncogene Proteins c-ret

Autor:innen und Institutionen

  • Department of Surgery, University of Chicago Medicine, Chicago, IL 60637, USA.

ORCID-Profile: Sara Abou Azar

Zitieren

APA

Abou Azar, S., Tobias, J., Applewhite, M., Angelos, P., & Keutgen, X. M. (2024). Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae279

Vancouver

Abou Azar S, Tobias J, Applewhite M, Angelos P, Keutgen XM. Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae279

BibTeX
@article{AbouAzar2024,
  author = {Abou Azar, Sara and Tobias, Joseph and Applewhite, Megan and Angelos, Peter and Keutgen, Xavier M},
  title = {Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae279}
}
Kostenlos starten →